ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Two-Step One-Pot Synthesis of
Benzoannulated Spiroacetals by
SuzukiꢀMiyaura Coupling/Acid-Catalyzed
Spiroacetalization
Alexey N. Butkevich,† Andrei Corbu,† Lieven Meerpoel,‡ Ian Stansfield,§
Patrick Angibaud,§ Pascal Bonnet,‡ and Janine Cossy*,†
Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS, 10 rue Vauquelin, 75231
Paris Cedex 05, France, Janssen Research & Development, Division of Janssen-Cilag
S.A., Oncology and Medicinal Chemistry, Campus de Maigremont, 27106 Val de Reuil,
Cedex, France, and Janssen Research & Development, Division of Janssen
Pharmaceutica N.V., Turnhoutsweg 30, 2340 Beerse, Belgium
Received July 27, 2012
ABSTRACT
Substituted benzoannulated spiroacetals were prepared from (2-haloaryl)alkyl alcohols and dihydropyranyl or dihydrofuranyl pinacol boronates
using a SuzukiꢀMiyaura coupling followed by an acid-catalyzed spirocyclization. Application of the reaction to a glycal boronate provides an
approach to annulated spiroacetals in enantiopure form.
The spiroacetal ring system, in particular 1,6-dioxaspiro-
[4.4]nonanes, 1,6-dioxaspiro[4.5]decanes, and 1,7-dioxaspiro-
[5.5]undecanes, is present in a variety of natural products
of different origins.1 Several benzoannulated spiroacetals,
such as rubromycins, heliquinomycin, papulacandin,
paecilospirone, and berkelic acid, have demonstrated potent
biological activity2 and therefore remain attractive synthetic
targets.
Spiroacetals have been prepared by acid-catalyzed cycliza-
tion of ω,ω0-dihydroxyketones,3 1,3-dipolar cycloaddition,4
oxidative enolate coupling,5 addition of 2-lithiofurans to
phenylacetaldehydes followed by cyclization,6 or an aro-
matic Pummerer-type reaction.7 Metal-catalyzed (Ir, Rh,
and Au) double hydroalkoxylation of disubstituted alkynes
provides benzoannulated spiroacetals; however these
reactions are rarely regioselective.8 Several syntheses of
† ESPCI ParisTech.
(5) Lindsey, C. C.; Wu, K. L.; Pettus, T. R. R. Org. Lett. 2006, 8,
2365–2367.
(6) Qin, D.; Ren, R. X.; Siu, T.; Zheng, C.; Danishefsky, S. J. Angew.
Chem., Int. Ed. 2001, 40, 4709–4713.
‡ Janssen Research & Development, Janssen Pharmaceutica N.V.
§ Janssen Research & Development, Oncology and Medicinal Chemistry,
Campus de Maigremont.
(1) Aho, J. E.; Pihko, P. M.; Rissa, T. K. Chem. Rev. 2005, 105, 4406–
4440. Denmark, S. E.; Regens, C. S.; Kobayashi, T. J. Am. Chem. Soc.
2007, 129, 2774–2776. Liu, G.; Wurst, J. M.; Tan, D. S. Org. Lett. 2009,
11, 3670–3673.
(7) Akai, S.; Kakiguchi, K.; Nakamura, Y.; Kuriwaki, I.; Dohi, T.;
Harada, S.; Kubo, O.; Morita, N.; Kita, Y. Angew. Chem., Int. Ed. 2007,
46, 7458–7461.
(8) Fugami, K.; Hagiwara, N.; Okeda, T.; Kosugi, M. Chem. Lett.
1998, 81–82. Li, X.; Chianese, A. R.; Vogel, T.; Crabtree, R. H. Org.
Lett. 2005, 7, 5437–5440. Messerle, B. A.; Vuong, K. Q. Organometallics
2007, 26, 3031–3040. Zhang, Y.; Xue, J.; Xin, Z.; Xie, Z.; Li, Y. Synlett
2008, 2008, 940–944. Selvaratnam, S.; Ho, J. H. H.; Huleatt, P. B.;
Messerle, B. A.; Chai, C. L. L. Tetrahedron Lett. 2009, 50, 1125–1127.
Ho, J. H. H.; Hodgson, R.; Wagler, J.; Messerle, B. A. Dalton Trans.
2010, 39, 4062–4069. Ho, J. H. H.; Choy, S. W. S.; Macgregor, S. A.;
Messerle, B. A. Organometallics 2011, 30, 5978–5984.
(2) Sperry, J.; Wilson, Z. E.; Rathwell, D. C. K.; Brimble, M. A. Nat.
Prod. Rep. 2010, 27, 1117–1137 and references cited therein.
(3) Tsang, K. Y.; Brimble, M. A.; Bremner, J. B. Org. Lett. 2003, 5,
€
4425–4427. Sorgel, S.; Azap, C.; Reissig, H.-U. Org. Lett. 2006, 8, 4875–
4878. Mainkar, P. S.; Johny, K.; Prabhakar Rao, T.; Chandrasekhar, S.
J. Org. Chem. 2012, 77, 2519–2525.
(4) Waters, S. P.; Fennie, M. W.; Kozlowski, M. C. Tetrahedron Lett.
2006, 47, 5409–5413.
r
10.1021/ol302088w
XXXX American Chemical Society